+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Melanoma"

Monoclonal Antibodies for Oncology: Global Markets - Product Thumbnail Image

Monoclonal Antibodies for Oncology: Global Markets

  • Report
  • June 2022
  • 124 Pages
  • Global
From
From
From
From
From
From
Immuno-oncology Development Trends and Opportunities - Product Thumbnail Image

Immuno-oncology Development Trends and Opportunities

  • Report
  • November 2018
  • 258 Pages
  • Global
From
Gene Therapy in Oncology - Thematic Research - Product Thumbnail Image

Gene Therapy in Oncology - Thematic Research

  • Report
  • June 2021
  • Global
From
Neoplasia and Fertility - Product Thumbnail Image

Neoplasia and Fertility

  • Book
  • September 2022
From
Oncology Markets for Tyrokinse Kinase Inhibitors - Product Thumbnail Image

Oncology Markets for Tyrokinse Kinase Inhibitors

  • Report
  • October 2021
  • 137 Pages
  • Global
From
Precision Medicine in Oncology. Edition No. 1 - Product Thumbnail Image

Precision Medicine in Oncology. Edition No. 1

  • Book
  • October 2020
  • 288 Pages
Oncology. Edition No. 1. Mount Sinai Expert Guides - Product Thumbnail Image

Oncology. Edition No. 1. Mount Sinai Expert Guides

  • Book
  • October 2019
  • 632 Pages
Loading Indicator

Melanoma is a type of cancer that affects the skin and is the most serious form of skin cancer. It is caused by the uncontrolled growth of pigment-producing cells, known as melanocytes. Melanoma is the fifth most common cancer in the United States, with an estimated 87,110 new cases in 2020. It is also the leading cause of death from skin disease. The melanoma market within the oncology space is a rapidly growing segment, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to be driven by the increasing adoption of targeted therapies, immunotherapies, and combination therapies. Additionally, the increasing focus on personalized medicine and the development of novel drug delivery systems are expected to drive the market. Some of the key players in the melanoma market include Bristol-Myers Squibb, Merck & Co., Novartis, Roche, Pfizer, and Eli Lilly. Show Less Read more